Humanized Mouse Models for Type 1 Diabetes.

Area of Science:

• Immunology
• Genetics
• Endocrinology

Background:

• Type 1 diabetes (T1D) is an autoimmune disease primarily driven by T cells and influenced by polygenic factors.
• Major histocompatibility complex (MHC) and human leukocyte antigen (HLA) variants are key genetic risk factors for T1D.
• Current NOD mouse models offer insights but have limitations in translating findings to human T1D.

Purpose of the Study:

• To review the development and application of humanized NOD mouse models for T1D research.
• To explore the use of CRISPR/Cas9 technology in creating these advanced preclinical models.
• To highlight the potential of these models for identifying clinically relevant T1D intervention strategies.

Main Methods:

• Utilizing CRISPR/Cas9 gene editing to generate NOD mice deficient in murine MHC.
• Introducing human HLA and T cell receptor (TCR) molecules into these modified mice.
• Characterizing the resulting humanized mouse models for their T1D pathogenesis.

Main Results:

• CRISPR/Cas9 enables the creation of murine-MHC-deficient NOD mice.
• These mice can be engineered to express patient-relevant HLA and TCR molecules.
• The humanized models better recapitulate human T1D development, offering improved platforms for study.

Conclusions:

• Humanized NOD mice represent a significant advancement in preclinical T1D research.
• These models facilitate the development and testing of novel, clinically translatable T1D interventions.
• This approach holds promise for advancing treatments for T1D and other autoimmune diseases.